RESPONSE OF LUTEINIZING-HORMONE SECRETING PITUITARY-ADENOMA TO A LONG-ACTING SOMATOSTATIN ANALOG

被引：24
|
作者：
VOS, P
CROUGHS, RJM
THIJSSEN, JHH
VANTVERLAAT, JW
VANGINKEL, LA
机构：
[1] STATE UNIV UTRECHT HOSP,DEPT ENDOCRINOL,CATHARIJNESINGEL 101,3511 GV UTRECHT,NETHERLANDS
[2] STATE UNIV UTRECHT HOSP,DEPT NEUROSURG,3511 GV UTRECHT,NETHERLANDS
[3] NATL INST PUBL HLTH & ENVIRONM HYG,BILTHOVEN,NETHERLANDS
来源：
ACTA ENDOCRINOLOGICA | 1988年 / 118卷 / 04期
关键词：
D O I：
10.1530/acta.0.1180587
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：587 / 590
页数：4
相关论文
共 50 条
  • [1] REVERSIBLE SHRINKAGE OF A GROWTH HORMONE-SECRETING PITUITARY-ADENOMA BY A LONG-ACTING SOMATOSTATIN ANALOG, OCTREOTIDE
    BARAKAT, S
    MELMED, S
    ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (06) : 1443 - 1445
  • [2] SHRINKAGE OF A PRIMARY THYROTROPIN-SECRETING PITUITARY-ADENOMA TREATED WITH THE LONG-ACTING SOMATOSTATIN ANALOG OCTREOTIDE (SMS-201-995)
    WARNET, A
    LAJEUNIE, E
    GELBERT, F
    DUET, M
    CHANSON, P
    COPHIGNON, J
    HARRIS, AG
    ACTA ENDOCRINOLOGICA, 1991, 124 (04): : 487 - 491
  • [3] RESPONSE OF THYROTROPIN-SECRETING PITUITARY-ADENOMAS TO A LONG-ACTING SOMATOSTATIN ANALOG
    COMI, RJ
    GESUNDHEIT, N
    MURRAY, L
    GORDEN, P
    WEINTRAUB, BD
    NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (01): : 12 - 17
  • [4] EFFECTS OF TREATMENT WITH A LONG-ACTING ANALOG OF LUTEINIZING-HORMONE RELEASING FACTOR
    SMITH, R
    DONALD, RA
    ESPINER, EA
    STRONACH, SG
    EDWARDS, IA
    NEW ZEALAND MEDICAL JOURNAL, 1979, 89 (631) : 188 - 188
  • [5] CYTOCIDAL EFFECTS OF BROMOCRIPTINE, SOMATOSTATIN ANALOG, AND HEAT ON GROWTH HORMONE-SECRETING PITUITARY-ADENOMA INVITRO
    KAWAMOTO, K
    UOZUMI, T
    SAKODA, K
    MUKADA, K
    KURISU, K
    YANO, T
    CANCER, 1992, 69 (11) : 2688 - 2696
  • [6] LONG-TERM TREATMENT WITH THE SOMATOSTATIN ANALOG SMS-201-995 IN A PATIENT WITH A THYROTROPIN-SECRETING AND GROWTH HORMONE-SECRETING PITUITARY-ADENOMA
    WEMEAU, JL
    DEWAILLY, D
    LEROY, R
    DHERBOMEZ, M
    MAZZUCA, M
    DECOULX, M
    JAQUET, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (03): : 636 - 639
  • [7] ABNORMAL RESPONSE OF LUTEINIZING-HORMONE BETA-SUBUNIT TO THYROTROPIN-RELEASING-HORMONE IN PATIENTS WITH NONFUNCTIONING PITUITARY-ADENOMA
    GILDELALAMO, P
    PETTERSSON, KSI
    SACCOMANNO, K
    SPADA, A
    FAGLIA, G
    BECKPECCOZ, P
    CLINICAL ENDOCRINOLOGY, 1994, 41 (05) : 661 - 666
  • [8] COMPARISON OF LONG-ACTING ANALOGS OF LUTEINIZING-HORMONE RELEASING HORMONE IN MAN
    WASS, JAH
    BESSER, GM
    GOMEZPAN, A
    SCANLON, MF
    HALL, R
    KASTIN, AJ
    COY, DH
    SCHALLY, AV
    CLINICAL ENDOCRINOLOGY, 1979, 10 (04) : 419 - 430
  • [9] REDUCTION IN SIZE OF A THYROTROPIN-SECRETING PITUITARY-ADENOMA TREATED WITH OCTREOTIDE ACETATE (SOMATOSTATIN ANALOG)
    LEE, EJ
    KIM, KR
    LIM, SK
    LEE, HC
    KIM, DI
    KIM, SH
    HUH, KB
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 131 (01) : 109 - 112
  • [10] REDUCTION IN SIZE OF A THYROTROPIN-SECRETING AND GONADOTROPIN-SECRETING PITUITARY-ADENOMA TREATED WITH OCTREOTIDE ACETATE (SOMATOSTATIN ANALOG)
    SY, RAG
    BERNSTEIN, R
    CHYNN, KY
    KOURIDES, IA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (03): : 690 - 694
12345